IGC Annual Filing Summary
Reporting period: India Globalization Capital, Inc. (the filing registrant; described in the request as IGC Pharma) filed a Form 10-K for the fiscal year ended March 31, 2015. This is an annual report, not a 2014 fourth-quarter filing. Financial statements are audited and presented in U.S. dollars.
Business context
IGC was shifting from legacy iron-ore and heavy-equipment activities toward electronic-component trading and development of phytocannabinoid-based therapies and related facilities. Electronic trading generated nearly all reported revenue; the biopharmaceutical effort was still in development and had no reported product revenue. The company acquired 51% of Hong Kong electronics trader Golden Gate, renamed IGC International, in May 2014. Its China iron-ore beneficiation plants were not operating during the year.
Financial performance and position
| Metric | FY ended Mar. 31, 2015 | FY ended Mar. 31, 2014 |
|---|---|---|
| Revenue | $7.68 million | $2.27 million |
| Cost of revenue | $7.10 million | $1.89 million |
| Gross profit / margin | $0.58 million / 7.5% | $0.38 million / 16.8% |
| Operating loss | $4.34 million | $2.53 million |
| Net loss attributable to common stockholders | $4.61 million; $0.31 per share | $3.02 million; $0.37 per share |
| Net cash used in operating activities | $2.58 million | $1.74 million |
| Cash and cash equivalents at year-end | $0.82 million | $1.03 million |
| Working capital | Approximately $2.03 million | Not stated in the provided text |
| Total liabilities | $5.58 million | $3.59 million |
Revenue rose 238%, primarily with the addition of electronics trading, but cost of revenue rose faster and gross margin contracted. Electronic components accounted for $7.61 million, or 99.1%, of FY2015 revenue; heavy-equipment rental contributed $70,956. SG&A rose to $4.14 million from $2.18 million. Management attributed about $2.4 million of FY2015 SG&A to specified items including stock-related charges, bad-debt write-downs, litigation settlements, acquisition costs and non-cash research and development.
Year-end borrowings included $1.28 million of short-term borrowing, $0.32 million of long-term borrowing and $1.80 million of notes payable. The $1.80 million note was due July 31, 2016 and had no cash interest payable; interest-related payments were made in stock. Cash-flow funding included $2.96 million from equity issuance and increased short-term borrowing. Management separately cited approximately $1.3 million of non-GAAP cash burn after adjustments for non-cash and one-time items; this differs from reported operating cash use of $2.58 million.
Changes, outlook and risks
- Revenue mix shifted from iron-ore trading in FY2014 to electronics trading in FY2015. Management said the higher component-purchasing costs reduced margins and identified obtaining distributorships or preferred purchasing status as a cost-reduction goal.
- Management expected margins and operating income to improve as its two main initiatives scaled, but gave no quantified financial guidance. It said further capital would be needed for expansion and identified an ATM program and bank facilities as potential funding sources.
- After year-end, IGC raised $400,000 through a convertible note, with conversion unavailable for six months and a 30% discount to market price upon conversion. Management also disclosed access to up to $450,000 in additional bank lines.
- Liquidity, continuing operating losses, dependence on additional capital, customer and component-supply exposure, foreign exchange, and the cost of compliance across multiple countries are material risks. Forty customers accounted for 80% of revenue; the three largest accounted for 15%.
- The Midtown Partners transaction was conditional on regulatory approvals. As of June 30, 2015, FINRA approval had not been obtained; the filing says 700,000 shares could be cancelled and a $125,000 penalty would apply, with a settlement being negotiated.
- IGC was negotiating return of its $150,000 TerraSphere advance. It had also advanced $400,000 toward U.S. property for vertical farming. Cannabis-related development faces U.S. federal prohibition and regulatory uncertainty.
- Other notable matters include an IGC lawsuit seeking cancellation of shares issued to HK Ironman shareholders, a disputed $25,800 Indian service-tax demand, aged airport-related receivables of about $0.5 million, and an approximately $5 million land settlement with Sricon that remained to be registered. The filing also reports litigation settlements among the items affecting expenses.
- The filing reports management’s conclusion that disclosure controls and internal control over financial reporting were effective, while its risk disclosures describe limited U.S. GAAP expertise and the possibility of financial-reporting weaknesses. The independent auditor issued an unqualified opinion.
Investor verification priorities
- Reconcile the reported FY2015 net loss figures: the statements show $4.68 million consolidated loss and $4.61 million attributable to common stockholders; management discussion sometimes refers to $4.61 million as the company’s loss.
- Check the timing and consolidation of IGC International’s results: the filing describes its acquisition as completed in May 2014, but the acquisition note states that only December 2014 operations were included in the consolidated results.
- Review the collectability and carrying value of aged receivables and advances, including the airport claim, employee advances, and TerraSphere and property-related amounts.
- Confirm the outcome of FINRA approval and the Midtown share cancellation, penalty and settlement; also track the HK Ironman share-cancellation lawsuit and Sricon land registration.
- Assess cash runway and financing dilution, including the convertible note, ATM capacity, bank facilities, outstanding warrants and options, and stock-based payments on debt.